Della Bella P, Baratto F, Vergara P, Bertocchi P, Santamaria M, Notarstefano P et al (2022) Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? results from the multicenter randomized PARTITA trial. Circulation 145(25):1829–1838
Article CAS PubMed Google Scholar
Santangeli P, Frankel DS, Tung R, Vaseghi M, Sauer WH, Tzou WS et al (2017) Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol 69(17):2105–2115
Cheng YJ, Li ZY, Yao FJ, Xu XJ, Ji CC, Chen XM et al (2017) Early repolarization is associated with a significantly increased risk of ventricular arrhythmias and sudden cardiac death in patients with structural heart diseases. Heart Rhythm 14(8):1157–1164
Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E et al (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375(9708):31–40
Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G et al (2008) Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 117(4):462–469
Martinez BK, Baker WL, Konopka A, Giannelli D, Coleman CI, Kluger J et al (2020) Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm 17(1):e206–e219
Zeppenfeld K, Wijnmaalen AP, Ebert M, Baldinger SH, Berruezo A, Catto V et al (2022) Clinical outcomes in patients with dilated cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol 80(11):1045–1056
Willems S, Tilz RR, Steven D, Kääb S, Wegscheider K, Gellér L et al (2020) Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation 141(13):1057–1067
Kimura Y, de Riva M, Ebert M, Glashan C, Wijnmaalen AP, Piers SR et al (2023) Pleomorphic ventricular tachycardia in dilated cardiomyopathy predicts ventricular tachycardia recurrence after ablation independent from cardiac function: comparison with patients with ischemic heart disease. Circ Arrhythm Electrophysiol 16(1):e010826
Article CAS PubMed Google Scholar
Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E et al (2009) EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm 6(6):886–933
Zachariah D, Limite LR, Mazzone P, Marzi A, Radinovic A, Baratto F et al (2022) Use of cerebral protection device in patients undergoing ventricular tachycardia catheter ablation. JACC Clin Electrophysiol 8(4):528–530
Sapp JL, Deyell MW (2017) Ventricular tachycardia ablation: should we be impelled to do more? JACC Clin Electrophysiol 3(13):1544–1546
Aryana A, Gearoid O’Neill P, Gregory D, Scotti D, Bailey S, Brunton S et al (2014) Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device. Heart Rhythm 11(7):1122–1130
Stanciulescu LA, Vatasescu R (2024) Ventricular Tachycardia Catheter Ablation: Retrospective Analysis and Prospective Outlooks—A Comprehensive Review. Biomedicines 12(2):266.
de Vries JW, Visser GH, Bakker PF (1997) Neuromonitoring in defibrillation threshold testing. A comparison between EEG, near-infrared spectroscopy and jugular bulb oximetry. J Clin Monit 13(5):303–7
Singer I, Edmonds H Jr (1994) Changes in cerebral perfusion during third-generation implantable cardioverter defibrillator testing. Am Heart J 127(4 Pt 2):1052–1057
Article CAS PubMed Google Scholar
McNeill E, Gagnon RE, Potts JE, Yeung-Lai-Wah JA, Kerr CR, Sanatani S (2005) Cerebral oxygenation during defibrillator threshold testing of implantable cardioverter defibrillators. Pacing Clin Electrophysiol 28(6):528–533
De Potter T, Valeriano C, Buytaert D, Bouchez S, Ector J (2023) Noninvasive neurological monitoring to enhance pLVAD-assisted ventricular tachycardia ablation - a mini review. Front Cardiovasc Med 10:1140153
Article PubMed PubMed Central Google Scholar
Miller MA, Dukkipati SR, Chinitz JS, Koruth JS, Mittnacht AJ, Napolitano C et al (2013) Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circ Arrhythm Electrophysiol 6(1):151–9
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726
Article CAS PubMed Google Scholar
Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA et al (2022) 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43(40):3997–4126
Mueller J, Chakarov I, Halbfass P, Nentwich K, Ene E, Berkovitz A, Sonne K, Barth S, Waechter C, Behnes M, Akin I (2023) Adverse prognosis of patients with septal substrate after VT ablation due to electrical storm. Clin Electrophysiol 9(6):790–804
la Cour A, Greisen G, Hyttel-Sorensen S (2018) In vivo validation of cerebral near-infrared spectroscopy: a review. Neurophotonics 5(4):040901
PubMed PubMed Central Google Scholar
Terakado T, Marushima A, Koyama Y, Tsuruta W, Takigawa T, Ito Y et al (2019) Effectiveness of near-infrared spectroscopy (NIRO-200NX, pulse mode) for risk management in carotid artery stenting. World Neurosurg 131:e425–e432
Saglietto A, Scarsoglio S, Canova D, Roatta S, Gianotto N, Piccotti A et al (2021) Increased beat-to-beat variability of cerebral microcirculatory perfusion during atrial fibrillation: a near-infrared spectroscopy study. Europace 23(8):1219–1226
Tarasova I, Trubnikova O, Kupriyanova DS, Maleva O, Syrova I, Kukhareva I et al (2023) Cognitive functions and patterns of brain activity in patients after simultaneous coronary and carotid artery revascularization. Front Hum Neurosci 17:996359
Article PubMed PubMed Central Google Scholar
Zheng F, Sheinberg R, Yee MS, Ono M, Zheng Y, Hogue CW (2013) Cerebral near-infrared spectroscopy monitoring and neurologic outcomes in adult cardiac surgery patients: a systematic review. Anesth Analg 116(3):663–676
Bennett SR, Smith N, Bennett MR (2022) Cerebral oximetry in adult cardiac surgery to reduce the incidence of neurological impairment and hospital length-of-stay: a prospective, randomized, controlled trial. J Intensive Care Soc 23(2):109–116
Murkin JM, Adams SJ, Novick RJ, Quantz M, Bainbridge D, Iglesias I et al (2007) Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg 104(1):51–58
Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA et al (2023) Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med 389(14):1286–1297
Article CAS PubMed Google Scholar
Moller JE, Engstrom T, Jensen LO, Eiskjaer H, Mangner N, Polzin A et al (2024) Microaxial flow pump or standard care in infarct-related cardiogenic shock. N Engl J Med 390(15):1382–1393
Sroubek J, Vajapey R, Sipko JJ, Soltesz EG, Weiss AJ, Bhargava M et al (2023) First-in-human experience with impella 5.0/5.5 for high-risk patients with advanced heart failure undergoing VT ablation. J Am Coll Cardiol. 82(5):469–71
Kobari M, Fukuuchi Y, Tomita M, Tanahashi N, Shinohara T, Yamawaki T et al (1992) Cerebral microcirculatory changes during and following transient ventricular tachycardia in cats. J Neurol Sci 111(2):153–157
留言 (0)